Drawing for ODYSSEY THERAPEUTICS

USPTO serial 98951736

ODYSSEY THERAPEUTICS

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
SETTLES LEWIS, SHAILA E
Law office
TMO LAW OFFICE 137

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ODYSSEY THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Dalton

Rebecca Dalton Covington & Burling LLPOne CityCenter, 850 Tenth Street NWWashington, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations for the treatment of auto-immune diseasesACTIVENov 5, 2026
042Providing medical and scientific research information in the field of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 16, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 16, 2026IUAFUSE AMENDMENT FILED—
Nov 16, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2026EX2GSOU EXTENSION 2 GRANTED—
Sep 30, 2026EXT2SOU EXTENSION 2 FILED—
Sep 30, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 31, 2026EX1GSOU EXTENSION 1 GRANTED—
Mar 31, 2026EXT1SOU EXTENSION 1 FILED—
Mar 31, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 14, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 19, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 19, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2025DOCKASSIGNED TO EXAMINER—
Jun 8, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 8, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance